ADALIMUMAB-AACF for Crohn's disease: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13 adverse event reports in the FDA FAERS database where ADALIMUMAB-AACF was used for Crohn's disease.
Most Reported Side Effects for ADALIMUMAB-AACF
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Abdominal pain upper | 11 | 7.9% | 0 | 9 |
| Axial spondyloarthritis | 10 | 7.1% | 0 | 10 |
| Drug ineffective | 9 | 6.4% | 0 | 1 |
| Psoriatic arthropathy | 9 | 6.4% | 0 | 8 |
| Nasopharyngitis | 8 | 5.7% | 0 | 7 |
| Reactive gastropathy | 8 | 5.7% | 0 | 8 |
| Spinal osteoarthritis | 8 | 5.7% | 0 | 8 |
| Arthralgia | 7 | 5.0% | 0 | 2 |
| Benign prostatic hyperplasia | 6 | 4.3% | 0 | 4 |
| Pain | 6 | 4.3% | 0 | 0 |
| Rheumatoid arthritis | 6 | 4.3% | 0 | 2 |
| Crohn's disease | 5 | 3.6% | 0 | 1 |
| Diarrhoea | 5 | 3.6% | 0 | 2 |
| Headache | 5 | 3.6% | 0 | 2 |
| Injection site pain | 5 | 3.6% | 0 | 0 |
Other Indications for ADALIMUMAB-AACF
Product used for unknown indication (43)
Rheumatoid arthritis (27)
Axial spondyloarthritis (11)
Psoriatic arthropathy (10)
Psoriasis (9)
Ankylosing spondylitis (7)
Other Drugs Used for Crohn's disease
ADALIMUMAB (99,540)
INFLIXIMAB (40,796)
VEDOLIZUMAB (28,718)
USTEKINUMAB (22,537)
RISANKIZUMAB-RZAA (12,561)
INFLIXIMAB-DYYB (10,657)
HUMIRA (10,174)
CERTOLIZUMAB PEGOL (8,758)
UPADACITINIB (4,390)
MESALAMINE (2,930)